Vaccine(s) were received on 11/02/2016
At the time of vaccination, patient was : 16 of age
Patient sex : M
Date reaction was reported: 04/02/2018
Reaction was life threatening?: N
Patient eventually recovered from reaction ?: Y
Patient eventually died?: N

The following Lab Data for this case is available: 01/01/2018, Full blood count, 22

The following Data for this patients ALLERGIES is available: [ ]

Description of adverse reaction: This case was reported by a consumer and described the occurrence of erythema in a 5-year-old male patient who received FLUARIX QUADRIVALENT (batch number 29PD2, expiry date unknown). Concomitant products included MMR. On 2nd November 2016, the patient received FLUARIX QUADRIVALENT .5 ml. On an unknown date, 1 day after receiving FLUARIX QUADRIVALENT, the patient experienced erythema, pruritus and swelling. The patient was treated with BENADRYL and Steroids. On an unknown date, the outcome of the erythema, pruritus and swelling were recovered/resolved. The reporter considered the erythema and swelling to be related to FLUARIX QUADRIVALENT. The reporter considered the pruritus to be unlikely related to FLUARIX QUADRIVALENT.

Vaccine(s) associated with report# 742769

Type	Name	Manufacturer	Vaccine LOT #	Dose Series	ROUTE	Site
FLU4	INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT)	GLAXOSMITHKLINE BIOLOGICALS	29PD2	0	UN	UN

Symptoms(s) associated with report# 742769

Erythema
Full blood count
Pruritus
Swelling